Hopes of a treatment for the coronavirus powered one S&P 500 biotech company more than 3% higher as global stock markets plunged.
The post Why This S&P 500 Stock Is Defying the Brutal Coronavirus Plunge appeared first on CCN.com
Source: https://www.ccn.com/why-this-sp-500-stock-is-defying-the-brutal-coronavirus-plunge/